Sign in

You're signed outSign in or to get full access.

Brandon O'Brien

Chief Financial Officer at CORVEL
Executive

About Brandon O'Brien

Brandon T. O’Brien (age 45) is CorVel’s Chief Financial Officer (Principal Financial Officer) and has served in the role since October 2018; he has been with CorVel since 2003 in finance and operating roles, and holds a B.S. in Business Administration from the University of Southern California . In fiscal 2025, CorVel delivered 13% revenue growth and 27% net income growth; over recent years, total shareholder return (value of $100) was $200 in FY2025, $256 in FY2024, and $349 in FY2023, contextualizing a pay-for-performance posture that emphasizes equity options and MBO-linked cash bonuses . The company prohibits hedging by insiders and maintains a Dodd-Frank–compliant clawback; there are no executive stock ownership guidelines, a modest alignment gap offset by option-heavy incentives tied to earnings growth .

Past Roles

OrganizationRoleYearsStrategic Impact
CorVelChief Financial Officer (Principal Financial Officer)Oct 2018 – PresentFinance leadership, MBO-linked performance oversight, equity program participant .
CorVelArea Vice President2015 – 2018Field operations/financial leadership across business units .
CorVelVice President, Business Operations2010 – 2015Operational execution and financial visibility initiatives .
CorVelDirector of Finance, Enterprise Comp2007 – 2010Enterprise compensation/finance analytics .
CorVelManager of Analytics2006 – 2007Analytics capabilities supporting operations and finance .

External Roles

No external public company directorships or outside board roles were disclosed for O’Brien in the proxy biography section .

Fixed Compensation

MetricFY2023FY2024FY2025
Base Salary ($)271,016 273,743 284,504
All Other Compensation ($)2,279 2,777 2,848
401(k) Match Included in “All Other” ($)2,025 2,250 2,300
Company-Paid Life Insurance Included in “All Other” ($)254 527 548

Notes:

  • CorVel offers broad-based perquisites (401(k) with discretionary match, ESPP at 5% discount, health/life insurance) and does not provide pension or non-qualified deferred compensation for executives .

Performance Compensation

Annual Cash Incentive (MBO Framework)

  • Annual cash incentives are MBO- and financial-performance–based; O’Brien’s target and realized payout percentages by calendar performance year are below (paid following fiscal year-end per proxy methodology) .
Calendar Year (Performance)Target Bonus (% of Salary)Actual Bonus (% of Salary)MBO Themes (Selected)
202240% 33.2% Invoicing; pricing insights; macro/micro financials
202340% 29.8% CERIS profitability analysis; financial visibility; automation; revenue leakage mitigation
202440% 36.8% P&C sales growth; financial-level improvements
202540% (target) — (not yet paid)P&C sales growth; financial-level improvements
  • Actual annual cash incentive dollars reported in SCT: FY2023 $85,709; FY2024 $80,701; FY2025 $103,788 .

Equity Awards (Grants in FY2025)

  • CorVel grants a mix of time-based options (25% cliff at 1 year, then 36 equal monthly installments; 5-year term) and performance-based options tied to undisclosed earnings growth criteria considered “rigorous” .
Grant DateAward TypeShares/Max (#)Exercise Price ($)Grant-Date Fair Value ($)Vesting / Notes
5/16/2024Time-based stock options750 90.08 20,208 25% at 1-year, then monthly over 36 months; 5-year term
1/14/2025Performance-based stock options2,000 (max) 110.18 63,779 Vests on achievement of earnings growth targets (undisclosed); 5-year term

Compensation Outcomes (SCT Components)

ComponentFY2023FY2024FY2025
Option Awards ($)65,996 150,702 83,987
Non-Equity Incentive Plan Comp ($)85,709 80,701 103,788
Total Compensation ($)424,999 507,923 475,127

Equity Ownership & Alignment

Beneficial Ownership (as of March 31, 2025)

HolderShares Beneficially Owned% Outstanding
Brandon T. O’Brien29,680 <1% (of 51,359,544 outstanding)

Notes:

  • Percentages are computed per SEC rules and include options exercisable within 60 days; figure is <1% for O’Brien .
  • No minimum stock ownership guidelines are in place for executive officers .
  • Insider trading policy prohibits hedging by employees, officers, and directors .
  • Under the 2025 Stock Incentive Plan, awards are generally non-transferable (may not be sold, pledged, assigned, etc., except by will or laws of descent) .

Option Exercises in FY2025 (Liquidity/Pressure Signal)

NameShares Acquired on Exercise (#)Value Realized on Exercise ($)
Brandon T. O’Brien8,950 665,612

Outstanding Equity Awards at FY-End (March 31, 2025)

Exercisable (#)Unexercisable (#)Exercise Price ($)ExpirationNotes
110.181/14/20302,000 performance-based options (unearned)
75090.085/16/2029Time-based grant
1,37366.8511/2/2028Plus 3,675 perf-based unearned
41763374.098/10/2028Time-based
1,56952.0011/3/2027Plus 3,000 perf-based unearned
1,06243849.635/12/2027Time-based
5,84765.7212/8/2026Time-based
2,1189339.835/6/2026Time-based
1,25029.2311/5/2025Time-based

Notes:

  • Performance-based options vest on achievement of earnings growth criteria approved by the Board/Compensation Committee; targets are not publicly disclosed .

Employment Terms

  • Employment: Executive officers, including O’Brien, have no individual employment agreements and are employed at-will .
  • Severance: No severance payments/benefits except in connection with a change-in-control transaction .
  • Change-in-Control Mechanics: Options generally accelerate immediately before the transaction unless assumed/replaced; committee retains authority to provide CIC-related acceleration .

Potential Payments on CIC Termination (as of March 31, 2025)

NameCash ($)Shares Subject to Accelerated Vesting (#)Value of Accelerated Option Vesting ($)
Brandon T. O’Brien13,636 764,697

Other governance terms:

  • Repricing of options/SARs without stockholder approval is prohibited under the 2025 Plan .
  • Clawback: Company maintains a policy compliant with Exchange Act Section 10D/Nasdaq to recoup incentive-based pay after material restatements (three-year lookback) .

Compensation Committee Analysis (Design, Benchmarks, Say-on-Pay)

  • Design: Three pillars—base salary, annual performance-based cash (MBO + financials), and long-term equity (options) .
  • Metrics: Annual incentives tied to revenue growth, net income, margin expansion, client retention, and strategic initiatives (e.g., CERIS, AI, P&C growth) .
  • Equity Mix: Time- and performance-based stock options; earnings-growth criteria determine vesting for performance options .
  • Market Data: Committee references managed care peers using data compiled by Alera Group (peer names not disclosed) .
  • Committee Membership (Board table): Compensation Committee includes Jeffrey J. Michael and Alan R. Hoops (independent directors) .
  • Say-on-Pay: ~92% approval at 2023 annual meeting, reinforcing continuity of design .

Performance & Track Record Context

Fiscal YearTSR: Value of $100 (Company)TSR: Value of $100 (Peer Group)Net Income ($000s)Diluted EPS ($)
2021188 149 46,356 0.85
2022309 124 66,410 1.22
2023349 116 66,365 1.26
2024256 85 76,252 1.47
2025200 96 95,165 1.83
  • FY2025 operational highlights used in incentive determinations include 13% revenue growth and 27% net income increase, alongside progress in CERIS platform expansion and AI deployment .

Risk Indicators & Red Flags

  • Hedging prohibited for insiders (alignment positive) .
  • No executive stock ownership guidelines (alignment gap) .
  • Repricing prohibited without shareholder approval (governance positive) .
  • Section 16 compliance: one late Form 4 (single transaction) for O’Brien on May 16, 2024 (process risk, low severity) .
  • Post-employment: No general severance; CIC acceleration of equity only (retention may rely on unvested/options value) .

Equity Ownership & Alignment Summary

  • Beneficial ownership: 29,680 shares; <1% of outstanding .
  • Vested/unvested/options: Substantial outstanding options across vintages with 2026–2030 expirations; performance-vested tranches tied to earnings growth .
  • Option exercise activity: 8,950 shares exercised in FY2025; $665,612 value realized (potential supply overhang consideration if monetized) .
  • Policies: Hedging prohibited; awards non-transferable/non-pledgeable; no disclosed pledging prohibition for already-owned shares; no ownership guidelines .

Employment Terms (Key Economics)

  • At-will employment; no individual employment agreement .
  • No severance multiples, tax gross-ups, or deferred compensation disclosed; no pension/SERP .
  • CIC: Full option acceleration unless awards are assumed/replaced; no separate cash severance; estimated acceleration value for O’Brien: $764,697 on 13,636 shares as of 3/31/25 .

Investment Implications

  • Pay-for-performance alignment is anchored in stock options (time- and performance-vested) with earnings-growth triggers; this leverages upside to shareholder value creation while maintaining cost discipline, aided by strong recent fundamentals (rev +13%, NI +27%) .
  • Alignment gaps include absence of stock ownership guidelines and sub-1% personal stake, partly mitigated by rigorous performance-vesting and anti-hedging policy; monitor future grants and net share retention to gauge increasing “skin in the game” .
  • Insider supply/trading: FY2025 option exercises (8,950 shares; $665,612 realized) and a laddered option expiry profile through 2030 suggest periodic exercise-driven liquidity; however, repricing prohibitions and 5-year terms constrain opportunism and encourage performance-focused vesting .
  • Retention and CIC dynamics: No cash severance and equity-only CIC benefits concentrate economics in unvested options and performance targets—supportive of retention in normal course, but with potential turnover risk in a low-ownership, option-heavy framework if equity becomes deeply out-of-the-money .
  • Governance signals: High prior say-on-pay approval (92%) and explicit clawback bolster governance quality; continue to watch Section 16 timeliness and any evolution toward RSUs/ownership guidelines that could alter risk-reward balance for executives and investors .